were 3.0% and 2.6% respectively (P=0.91); all INF sites were in the ipsilateral supraclavicular fossa. Medastinal N3 disease was the risk factor for INF (P=0.02, OR=14.13, 95%CI: 1.47-136.13). During radiotherapy, grade I, II weight loss was observed in 29.4%, 5.9% and 56.4%, 7.7% patients respectively (P=0.04). Grade 0-I and II-III late pulmonary injury was developed in 97.1%, 2.9% and 86.4%, 15.4% patients respectively (P=0.07). Median survival time was 22.1 months and 26.9 months respectively. The 1 to 3-year OS were 77.9%, 44.4%, 37.3% and 75.8%, 56.3%, 41.7% respectively (P=0.79). Conclusion The preliminary results of this study indicate that irradiant the post-chemotherapy tumor extent (GTV-T) and positive nodal drainage area did not decrease local control and overall survival while radiation toxicity was reduced. But the current sample size has not met designed requirements, and further investigation is warranted before final conclusions could be drawn.
【Key De Ruysscher等 [19] 率先开展了对LSCLC患者忽略纵 隔ENI的临床研究，结果显示11%（3/27）患者发生单 Post-or pre-chemotherapy tumor extent, omission of ENI Kies et al [18] 494 2D Pos t-or p re -che mothe rapy tumor e x te nt , "ab nor mal appearing lung" , mediastinal, "low" supraclavicular fossa
De Ruysscher et al [19] 27 3D Pre-chemotherapy tumor extent, omission of ENI 表 6 本研究与另外两项前瞻性研究的比较 和B超（P<0.001）均比触诊更能有效地诊断锁骨上淋
De Ruysscher等 [19] 
